Viewing StudyNCT04810611



Ignite Creation Date: 2024-05-06 @ 3:56 PM
Last Modification Date: 2024-10-26 @ 2:00 PM
Study NCT ID: NCT04810611
Status: TERMINATED
Last Update Posted: 2024-05-17
First Post: 2021-03-09

Brief Title: Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Keywords:
Name View
MDS View
Myelodysplastic View
myelodysplastic syndrome View